AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Anixa Biosciences Inc Director's Dealing 2018

Oct 1, 2018

34117_dirs_2018-10-01_8926d28e-74a8-4192-a7c8-4c3d83c45f71.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Anixa Biosciences Inc (ANIX)
CIK: 0000715446
Period of Report: 2018-09-27

Reporting Person: Cavalier David (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct